Advertisement

Multidisciplinary selection of pulmonary nodules for surgical resection: Diagnostic results and long-term outcomes

Published:September 24, 2019DOI:https://doi.org/10.1016/j.jtcvs.2019.09.030

      Abstract

      Objective

      Pulmonary nodules found incidentally or by lung cancer screening differ in prevalence, risk profile, and diagnostic intervention. The results of surgical intervention for incidental versus screening lung nodules during multidisciplinary Pulmonary Nodule and Lung Cancer Screening Clinic (PNLCSC) follow-up have not been reported.

      Methods

      All patients evaluated at a PNLCSC from 2012 to 2018 following referral by primary care physicians, specialist physicians, or self-referral after computed tomography (CT) identified nodules on routine diagnostic CT (incidental group) or lung cancer screening CT (screening group) were included. Follow-up interval, invasive intervention, histology, postoperative events, survival, and recurrence were compared.

      Results

      Of 747 patients evaluated in the PNLCSC, 129 (17.2%) underwent surgical intervention. The surgical cohort consisted of 104 (80.6%) incidental and 25 (19.3%) screening patients followed over a mean of 122 and 70 days, respectively. More benign lesions were excised in the incidental group (20.2%, 21/104)—representing 3.3% (21/632) of all incidental nodules evaluated—than in the screening group (4%, 1/25) (P = .038). Operative mortality was zero. Among 99 patients with primary lung cancer, 87% (screening) and 86.8% (incidental) were pathologic stage Ia. Complete follow-up was available in 725 of 747 (97%), and no patient developed progressive disease. Disease-free survival at 5 years was 74.9% (incidental) and 89.3% (screening) (P = .48).

      Conclusions

      A unique multidisciplinary PNLCSC for incidental and lung cancer screening–detected nodules with individualized risk assessment reliably identifies primary and metastatic tumors while exposing few patients to diagnostic excision for benign disease. Longer-term outcomes, strategies to limit radiation exposure, and cost control need further study.

      Graphical abstract

      Key Words

      Abbreviations and Acronyms:

      CT (computed tomography), lung-RADS (lung imaging reporting and data system), MGH (Massachusetts General Hospital), PET (positron emission tomography), PNLCSC (Pulmonary Nodule and Lung Cancer Screening Clinic), SBRT (stereotactic body radiation therapy)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and PersonalCorporate R&D Professionals
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Smith-Bindman R.
        • Miglioretti D.L.
        • Johnson E.
        • Lee C.
        • Feigelson H.S.
        • Flynn M.
        • et al.
        Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010.
        JAMA. 2012; 307: 2400-2409
        • Ost D.
        • Fein A.M.
        • Feinsilver S.H.
        Clinical practice. The solitary pulmonary nodule.
        N Engl J Med. 2003; 348: 2535-2542
        • Gould M.K.
        • Tang T.
        • Liu I.L.
        • Lee J.
        • Zheng C.
        • Danforth K.N.
        • et al.
        Recent trends in the identification of incidental pulmonary nodules.
        Am J Respir Crit Care Med. 2015; 192: 1208-1214
        • Korst R.J.
        Systematic approach to the management of the newly found nodule on screening computed tomography: role of dedicated pulmonary nodule clinics.
        Thorac Surg Clin. 2013; 23: 141-152
        • National Lung Screening Trial Research Team
        • Aberle D.R.
        • Adams A.M.
        • Berg C.D.
        • Black W.C.
        • Clapp J.D.
        • et al.
        Reduced lung-cancer mortality with low-dose computed tomographic screening.
        N Engl J Med. 2011; 365: 395-409
        • Oudkerk M.
        • Heuvelmans M.A.
        Screening for lung cancer by imaging: the Nelson study.
        JBR-BTR. 2013; 96: 163-166
        • Walter J.E.
        • Heuvelmans M.A.
        • de Bock G.H.
        • Yousaf-Khan U.
        • Groen H.J.M.
        • van der Aalst C.M.
        • et al.
        Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: the NELSON study.
        Lung Cancer. 2018; 125: 103-108
        • Bach P.B.
        • Mirkin J.N.
        • Oliver T.K.
        • Azzoli C.G.
        • Berry D.A.
        • Brawley O.W.
        • et al.
        Benefits and harms of CT screening for lung cancer: a systematic review.
        JAMA. 2012; 307: 2418-2429
        • Fintelmann F.J.
        • Bernheim A.
        • Digumarthy S.R.
        • Lennes I.T.
        • Kalra M.K.
        • Gilman M.D.
        • et al.
        The 10 pillars of lung cancer screening: rationale and logistics of a lung cancer screening program.
        Radiographics. 2015; 35: 1893-1908
        • Fintelmann F.J.
        • Gottumukkala R.V.
        • McDermott S.
        • Gilman M.D.
        • Lennes I.T.
        • Shepard J.O.
        Lung cancer screening: why, when, and how?.
        Radiol Clin North Am. 2017; 55: 1163-1181
        • Campo M.J.
        • Lennes I.T.
        Managing patients with screen-detected nodules: the nodule clinic.
        Semin Roentgenol. 2017; 52: 161-165
        • Gilbert C.R.
        • Ely R.
        • Fathi J.T.
        • Louie B.E.
        • Wilshire C.L.
        • Modin H.
        • et al.
        The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic.
        J Thorac Cardiovasc Surg. 2018; 155: 416-424
        • Miller D.L.
        • Mayfield W.R.
        • Luu T.D.
        • Helms G.A.
        • Muster A.R.
        • Beckler V.J.
        • et al.
        Community-based multidisciplinary computed tomography screening program improves lung cancer survival.
        Ann Thorac Surg. 2016; 101: 1864-1869
        • Crestanello J.A.
        • Allen M.S.
        • Jett J.R.
        • Cassivi S.D.
        • Nichols III, F.C.
        • Swensen S.J.
        • et al.
        Thoracic surgical operations in patients enrolled in a computed tomographic screening trial.
        J Thorac Cardiovasc Surg. 2004; 128: 254-259
        • Flores R.
        • Bauer T.
        • Aye R.
        • Andaz S.
        • Kohman L.
        • Sheppard B.
        • et al.
        Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer.
        J Thorac Cardiovasc Surg. 2014; 147: 1619-1626
        • Gillaspie E.A.
        • Allen M.S.
        Computed tomographic screening for lung cancer: the Mayo Clinic experience.
        Thorac Surg Clin. 2015; 25: 121-127
        • Wilson D.O.
        • Weissfeld J.L.
        • Fuhrman C.R.
        • Fisher S.N.
        • Balogh P.
        • Landreneau R.J.
        • et al.
        The Pittsburgh lung screening study (PLuSS): outcomes within 3 years of a first computed tomography scan.
        Am J Respir Crit Care Med. 2008; 178: 956-961
        • MacMahon H.
        • Austin J.H.
        • Gamsu G.
        • Herold C.J.
        • Jett J.R.
        • Naidich D.P.
        • et al.
        Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.
        Radiology. 2005; 237: 395-400
        • MacMahon H.
        • Naidich D.P.
        • Goo J.M.
        • Lee K.S.
        • Leung A.N.C.
        • Mayo J.R.
        • et al.
        Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017.
        Radiology. 2017; 284: 228-243
        • Naidich D.P.
        • Bankier A.A.
        • MacMahon H.
        • Schaefer-Prokop C.M.
        • Pistolesi M.
        • Goo J.M.
        • et al.
        Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society.
        Radiology. 2013; 266: 304-317
        • Sharma A.
        • McDermott S.
        • Mathisen D.J.
        • Shepard J.O.
        Preoperative localization of lung nodules with fiducial markers: feasibility and technical considerations.
        Ann Thorac Surg. 2017; 103: 1114-1120
        • Wood D.E.
        • Kazerooni E.A.
        • Baum S.L.
        • Eapen G.A.
        • Ettinger D.S.
        • Hou L.
        • et al.
        Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology.
        J Natl Compr Canc Netw. 2018; 16: 412-441
        • Walker B.L.
        • Williamson C.
        • Regis S.M.
        • McKee A.B.
        • D'Agostino R.S.
        • Hesketh P.J.
        • et al.
        Surgical outcomes in a large, clinical, low-dose computed tomographic lung cancer screening program.
        Ann Thorac Surg. 2015; 100: 1218-1223
        • Chung K.
        • Jacobs C.
        • Scholten E.T.
        • Goo J.M.
        • Prosch H.
        • Sverzellati N.
        • et al.
        Lung-RADS category 4X: does it improve prediction of malignancy in subsolid nodules?.
        Radiology. 2017; 284: 264-271

      Linked Article

      • The “multispecialty clinic”: Toward a new paradigm in thoracic oncology?
        The Journal of Thoracic and Cardiovascular SurgeryVol. 160Issue 3
        • Preview
          We read with interest the article “Multidisciplinary Selection of Pulmonary Nodules for Surgical Resection: Diagnostic Results and Long-term Outcomes” by Madariaga and colleagues.1 We want to comment from a somewhat philosophical point of view. We began a similar multispecialty pulmonary nodule clinic in early 2013 and briefly reported our preliminary experience in 2015.2 At the root of this initiative was an intuition that the nature of pulmonary oncology was changing. We were seeing more and more frail patients with multiple health issues.
        • Full-Text
        • PDF